V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20192517 | 20088250 | 1.51 | 16 | null | 2018-11-16 | 2018-11-23 | Bortezomib +/- Dexamethasone | Y | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 100811264 |
| 20192598 | 20088251 | 1.7 | null | Palliative (P) | null | 2019-10-24 | FOXFIRE TRIAL | 01 | N | NAB-PACLITAXEL | 101596904 |
| 20192633 | 20088252 | 1.77 | 77.8 | Palliative (P) | 2017-11-15 | 2017-11-15 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | HYDROXYCARBAMIDE | 100468754 |
| 20192742 | 20088254 | 1.58 | 81 | 03 | 2019-09-13 | 2019-09-17 | Doxorubin 50mg/m2 | 02 | N | INTERFERON ALFA | 101745228 |
| 20192799 | 20088255 | 1.6 | 71 | Curative (C) | 2017-02-10 | 2017-02-10 | MCX | 02 | N | IBRUTINIB | 101216402 |
| 20192828 | 20088256 | 1.49 | 40.45 | 03 | 2016-06-06 | 2016-06-14 | Capecitabine + Streptozocin | N | N | CARBOPLATIN + RALTITREXED | 100317739 |
| 20192833 | 20088257 | 1.73 | 61 | null | 2017-12-02 | 2017-12-16 | SCOPE 2 TRIAL | 02 | N | IBRUTINIB | 100021901 |
| 20193222 | 20088261 | 1.75 | 73.6 | 03 | 2018-09-26 | 2018-09-27 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | PAZOPANIB | 100115083 |
| 20193271 | 20088262 | null | null | null | 2020-05-17 | 2020-05-17 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 02 | N | IPILIMUMAB + NIVOLUMAB | 101417617 |
| 20193289 | 20088263 | 1.81 | null | Palliative (P) | 2016-12-16 | 2017-01-14 | Carboplatin + Pemetrexed | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100199920 |
| 20193334 | 20088264 | 1.75 | 76.6 | null | 2017-04-03 | 2017-04-17 | Cisplatin + Pemetrexed | N | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100192807 |
| 20193430 | 20088265 | 1.79 | 76 | Palliative (P) | null | 2019-12-13 | PACLITAXEL | null | N | CARBOPLATIN + VINORELBINE | 100585734 |
| 20193505 | 20088266 | 0 | 0 | null | 2016-07-04 | 2016-07-18 | FCarboSt | 02 | N | BACILLUS CALMETTE-GUERIN | 100343472 |
| 20193514 | 20088267 | 1.86 | 66.5 | Palliative (P) | 2019-01-17 | 2019-01-21 | CHOP R - 21 days | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100967649 |
| 20193552 | 20088268 | 1.8 | 78.5 | 03 | null | 2019-09-11 | Everolimus 10mg | N | N | CEMIPLIMAB | 100636346 |
| 20193556 | 20088269 | 1.7 | 91.7 | null | 2017-12-14 | 2018-06-29 | PEMBROLIZUMAB | N | N | OXALIPLATIN + MDG + PANITUMUMAB | 100274232 |
| 20193570 | 20088270 | 1.54 | 52.1 | 03 | 2019-05-25 | 2019-06-18 | EC | N | N | CISPLATIN + DOCETAXEL | 101161891 |
| 20193638 | 20088271 | 1.92 | 84.2 | Palliative (P) | 2019-07-06 | 2019-07-27 | ACELARATE Trial | N | N | CYTARABINE | 101825471 |
| 20193652 | 20088272 | 1.78 | 79.6 | Palliative (P) | 2020-02-13 | 2020-02-13 | ARISTOTLE TRIAL | 01 | N | PEMBROLIZUMAB | 100783456 |
| 20193715 | 20088273 | 1.7 | 70 | 03 | 2019-02-28 | 2019-03-13 | PACLITAXEL | 02 | N | MITOMYCIN | 100937527 |
| 20193737 | 20088274 | 1.7 | 80 | Palliative (P) | 2020-05-07 | 2020-05-07 | Carboplatin+Fluorouracil 4 or 5 day | 01 | N | HYDROXYCARBAMIDE | 101698611 |
| 20193764 | 20088275 | 1.77 | 56.1 | Adjuvant (A) | 2017-08-23 | 2017-09-03 | ESPAC-4 TRIAL | 02 | N | PACLITAXEL | 100878145 |
| 20193788 | 20088276 | 1.65 | 71.6 | Palliative (P) | 2018-11-29 | 2018-12-07 | null | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100021253 |
| 20193816 | 20088277 | 0 | 0 | Adjuvant (A) | 2019-05-04 | 2019-05-04 | CAPECITABINE + CETUXIMAB + IRINOTECAN | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100567206 |
| 20193856 | 20088278 | 0 | 0 | Palliative (P) | 2017-02-12 | 2017-02-26 | Bevacizumab + CARBOPLATIN + PACLITAXEL | null | N | CISPLATIN + VINORELBINE | 101177431 |
| 20193900 | 20088279 | 1.74 | 82.5 | Adjuvant (A) | null | 2020-01-22 | PLATFORM Trial + MEDI4736 | N | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101860549 |
| 20193912 | 20088280 | 1.84 | 59.3 | 03 | 2019-10-28 | 2019-11-15 | Bortezomib + Cyclophos + Dex | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100588572 |
| 20194043 | 20088281 | 1.71 | 75 | Palliative (P) | 2017-06-23 | 2017-06-29 | MPV (cycle 1-4) | 02 | null | CARBOPLATIN + EPIRUBICIN | 100947585 |
| 20194172 | 20088282 | 1.73 | 69 | 03 | 2017-09-10 | 2017-10-13 | GO2 TRIAL | 02 | N | BENDAMUSTINE + RITUXIMAB | 100352389 |
| 20194333 | 20088283 | 1.63 | 99 | 03 | 2017-04-02 | 2017-04-09 | PACLITAXEL | 01 | N | AZACITIDINE | 101363448 |
| 20194445 | 20088285 | 1.77 | 71.6 | Palliative (P) | 2017-11-12 | 2017-12-15 | CHOP R - 21 days | N | N | NOT MATCHED | 100408192 |
| 20194533 | 20088286 | 1.6 | 81.9 | Palliative (P) | 2017-01-03 | 2017-01-17 | Ralitrexed | N | N | FOXTROT TRIAL | 100062470 |
| 20194671 | 20088287 | 1.75 | 83 | Palliative (P) | 2018-08-10 | 2018-08-10 | ARISTOTLE TRIAL | 02 | N | ABIRATERONE | 100746772 |
| 20194720 | 20088288 | 1.73 | 119 | 03 | 2018-09-17 | 2018-09-17 | ARISTOTLE TRIAL | 02 | N | ERIBULIN | 100534322 |
| 20194727 | 20088289 | 1.71 | 60.2 | Palliative (P) | 2016-06-08 | 2016-06-10 | PHITT Trial | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101849873 |
| 20194746 | 20088290 | 1.55 | 78.6 | 03 | 2016-04-09 | 2016-04-16 | Fluorouracil + Folinic + RT Bossett | N | N | NOT MATCHED | 101348927 |
| 20194882 | 20088291 | 1.52 | 108.6 | Curative (C) | 2018-12-31 | 2019-01-02 | IBRUTINIB | 02 | N | CYCLOPHOSPHAMIDE | 100175880 |
| 20195081 | 20088293 | 1.67 | 82.3 | Palliative (P) | 2018-12-24 | 2018-12-24 | Fluorouracil + Folinic + RT Bossett | 02 | N | OXALIPLATIN | 100873840 |
| 20195087 | 20088294 | 1.52 | 51 | Palliative (P) | 2019-11-24 | 2019-11-27 | ESPAC-4 TRIAL | N | N | AFATINIB | 100076109 |
| 20195099 | 20088295 | 1.66 | 94.7 | Palliative (P) | 2019-11-09 | 2019-11-20 | DA 3 + 10 | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101038842 |
| 20195172 | 20088296 | 1.6 | 73.9 | 03 | 2015-11-04 | 2015-11-05 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | CVD | 100305940 |
| 20195211 | 20088297 | 1.56 | 75.5 | Palliative (P) | 2018-12-20 | 2018-12-20 | FCarboSt | 2 | N | CARBO + FLUOROURACIL | 100134615 |
| 20195246 | 20088298 | 1.87 | 55.2 | 03 | 2018-02-04 | 2018-02-17 | CHOP R | 02 | N | SUNITINIB | 100088013 |
| 20195253 | 20088299 | 1.78 | 90 | Palliative (P) | 2014-10-01 | 2014-11-13 | ESPAC-4 TRIAL | 02 | N | ESPAC TRIAL | 100199770 |
| 20195460 | 20088300 | 1.52 | 86 | Palliative (P) | null | 2019-03-14 | MCX | 02 | N | LIPOSOMAL DOXORUBICIN | 101552716 |
| 20195509 | 20088301 | 1.64 | 73.3 | null | 2016-08-13 | 2016-08-13 | ACTICCA-1 Trial | Y | N | FCARBOST | 101328803 |
| 20195541 | 20088302 | 1.68 | 64.2 | Adjuvant (A) | 2018-02-13 | 2018-02-17 | CAP + RT | 02 | Y | OXALIPLATIN | 101549328 |
| 20195619 | 20088303 | 1.7 | 62 | Palliative (P) | 2017-09-13 | 2017-09-26 | PEMBROLIZUMAB | N | N | CISPLATIN + FLUOROURACIL + RT | 100999196 |
| 20195643 | 20088304 | 1.61 | 115 | null | 2018-04-22 | 2018-04-29 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 101731291 |
| 20195682 | 20088305 | 1.51 | 95.4 | 03 | 2017-11-23 | 2017-12-04 | OXALIPLATIN | N | N | CISPLATIN + FLUOROURACIL + RT | 100723794 |